145 related articles for article (PubMed ID: 11164506)
1. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Clark JM
Antiviral Res; 2000 Dec; 48(3):197-203. PubMed ID: 11164506
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.
Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Standring DN; Clark JM
Antimicrob Agents Chemother; 1998 Dec; 42(12):3209-17. PubMed ID: 9835516
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
Seifer M; Hamatake RK; Colonno RJ; Standring DN
Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
11. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside analogues alone or combined with vaccination prevent hepadnavirus viremia and induce protective immunity: alternative strategy for hepatitis B virus post-exposure prophylaxis.
Wang B; Zhu Z; Zhu B; Wang J; Song Z; Huang S; Fan W; Tao Y; Wang Z; Wang H; Lu M; Yang D
Antiviral Res; 2014 May; 105():118-25. PubMed ID: 24583157
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
14. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
Michalak TI; Zhang H; Churchill ND; Larsson T; Johansson NG; Oberg B
Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
[TBL] [Abstract][Full Text] [Related]
15. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus.
Ikeda N; Kaneko S; Shimoda A; Inagaki Y; Unoura M; Okada M; Yonekawa Y; Takahashi K; Kobayashi K
J Antimicrob Chemother; 1994 Jan; 33(1):83-9. PubMed ID: 8157578
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection.
Meng Z; Zhang X; Pei R; Zhang E; Kemper T; Vollmer J; Davis HL; Glebe D; Gerlich W; Roggendorf M; Lu M
Antiviral Res; 2016 Jan; 125():14-24. PubMed ID: 26585244
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
[TBL] [Abstract][Full Text] [Related]
19. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
20. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.
Liu J; Zhang E; Ma Z; Wu W; Kosinska A; Zhang X; Möller I; Seiz P; Glebe D; Wang B; Yang D; Lu M; Roggendorf M
PLoS Pathog; 2014 Jan; 10(1):e1003856. PubMed ID: 24391505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]